Citations

Mayo Clinic

Showing 10 of 108599 citations.

Differential Incorporation of Tau Isoforms in Alzheimer's Disease
Espinoza, Marisol, Silva, Rohan de , Dickson, Dennis W. , Davies, Peter

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 14 | Issue: 1 | Pages: 1-16

10.3233/jad-2008-14101 | PMID 18525123 Get It

Inhibition of PHF-like Tau Hyperphosphorylation in SH-SY5Y Cells and Rat Brain Slices by K252a
Hübinger, Gabriele, Geis, Silvia, LeCorre, Sylvie, Mühlbacher, Susanne, Fracasso, Rafael , Hoffman, F.O. , Ferrand, Sandrine, Klafki, Hans‐Wolfgang , Roder, Hanno M., Gordon, Sandra Leigh

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 13 | Issue: 3 | Pages: 281-294

10.3233/jad-2008-13306 | PMID 18430996 Get It

Cognitive Performance Correlates with Cortical Isopeptide Immunoreactivity as Well as Alzheimer Type Pathology
Wang, Deng-Shun, Uchikado, Hirotake, Bennett, David A. , Mufson, Elliott J. , Bennett, David A. , Schneider, Julie A. , Wu, Joanne , Dickson, Dennis W.

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 13 | Issue: 1 | Pages: 53-66

10.3233/jad-2008-13106 | PMID 18334757 Get It

Mild Cognitive Impairment: Is it Alzheimer's disease or Not?
Petersen, Ronald C. , Bennett, David A. , Bennett, David A.

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 7 | Issue: 3 | Pages: 241-245

10.3233/jad-2005-7307 | PMID 16006668 Get It

Assembly of filamentous tau aggregates in human neuronal cells
Ko, Li‐wen, Rush, Toni, Kersh, Jay S., Easson, Colin, DeTure, Michael , Lin, Wen-Lang, Connor, Yamicia , Yen, Shu-Hui, Sahara, Naruhiko

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 6 | Issue: 6 | Pages: 605-622

10.3233/jad-2004-6605 | PMID 15665401 Get It

Iliopsoas Impingement After Primary Total Hip Arthroplasty: Operative and Nonoperative Treatment Outcomes
Sculco, Peter K. , Trousdale, Robert T. , Berry, Daniel J. , Chalmers, Brian P. , Sierra, Rafael J. , Berry, Daniel J

Journal of Bone and Joint Surgery | April 5, 2017 | Volume: 99 | Issue: 7 | Pages: 557-564

10.2106/jbjs.16.00244 | PMID 28375888 Get It

Background: A potential cause of persistent groin pain after total hip arthroplasty is impingement of the iliopsoas tendon. Treatment options include conservative management, tenotomy, and acetabular revision, but the literature, to our knowledge, has been limited to small case series on each technique. We present a series of patients with iliopsoas impingement after total hip arthroplasty and evaluate efficacy and risk factors for success or failure of each treatment strategy. Methods: Forty-nine patients treated at one institution for a diagnosis of iliopsoas impingement after primary total hip arthroplasty with hemispherical acetabular component and polyethylene bearing were retrospectively reviewed. Twenty-one patients underwent acetabular revision, 8 patients underwent tenotomy, and 20 patients had nonoperative management. The mean follow-up was 4 years. Anterior acetabular component prominence was measured on true lateral hip radiographs. Results: At the most recent follow-up, 10 patients (50%) in the nonoperative group had groin pain resolution compared with 22 patients (76%) in the operative group (p = 0.06). In patients with <8 mm of component prominence, tenotomy provided resolution of groin pain in 5 (100%) of 5 patients and a mean Harris hip score of 89 points. In patients with ≥8 mm of prominence, acetabular revision led to groin pain resolution in 12 (92%) of 13 patients compared with 1 (33%) of 3 patients treated with tenotomy (p = 0.07). Conclusions: Nonoperative management of iliopsoas impingement led to groin pain resolution in 50% of patients. In patients with minimal acetabular component prominence, iliopsoas release provided a high rate of success. Acetabular revision was more predictable for groin pain resolution in patients with ≥8 mm of anterior component prominence. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Unplanned Readmissions Following Outpatient Hand and Elbow Surgery
Noureldin, Mohamed , Habermann, Elizabeth B. , Ubl, Daniel S. , Kakar, Sanjeev , Habermann, Elizabeth

Journal of Bone and Joint Surgery | April 5, 2017 | Volume: 99 | Issue: 7 | Pages: 541-549

10.2106/jbjs.15.01423 | PMID 28375886 Get It

Background: Unplanned readmission following surgery is a quality metric that helps surgeons assess initiatives targeted at improving patient care. We utilized the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database to determine the rates, causes, and predictors of unplanned 30-day readmissions after outpatient elective hand and elbow surgery. Methods: The ACS-NSQIP database was queried using hand-and-elbow-specific Current Procedural Terminology (CPT) codes to retrospectively identify patients who had undergone outpatient hand or elbow surgery in 2012 and 2013. Patients who required an unplanned readmission to the hospital within 30 days were compared with those who were not readmitted. Preoperative patient characteristics, intraoperative variables, complications, and mortality were compared between the cohorts. Cox proportional hazard models were used to determine independent associations with 30-day unplanned readmission. Results: A total of 14,106 outpatient hand or elbow surgery procedures were identified between 2012 and 2013, and 169 (1.2%) of them were followed by an unplanned readmission. The leading causes of readmission included postoperative infections (19.5%), pain (4.7%), thromboembolic events (4.1%), and pulmonary complications (3.0%). The causes of approximately 1/3 of the readmissions were missing from the database, and these readmissions were likely unrelated to the principal procedure. Independent predictors of readmission included an age of 70 to 84 years (hazard ratio [HR] = 2.83, 95% confidence interval [CI] = 1.67 to 4.78), smoking (HR = 2.23, 95% CI = 1.57 to 3.18), a lower hematocrit (HR = 2.19, 95% CI = 1.38 to 3.46), renal dialysis (HR = 3.32, 95% CI = 1.60 to 6.91), and an elbow procedure (with or without a hand procedure) (HR = 2.19, 95% CI = 1.57 to 3.04). Conclusions: The prevalence of unplanned readmission following outpatient hand and elbow surgery is low. Several modifiable factors, including preoperative smoking and anemia, are associated with unplanned readmission. These data may be helpful in developing quality-control initiatives to target unplanned readmissions following hand and elbow procedures. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Nicotine lowers the secretion of the Alzheimer's amyloid β-protein precursor that contains amyloid β-peptide in rat
Utsuki, Tadanobu, Shoaib, Mohammed , Holloway, Harold W., Ingram, Donald K. , Wallace, William, Haroutunian, Vahram , Sambamurti, Kumar , Lahiri, Debomoy K. , Greig, Nigel H.

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 4 | Issue: 5 | Pages: 405-415

10.3233/jad-2002-4507 | PMID 12446972 Get It

The genetic causes of neurodegenerative diseases
Hardy, John , Hardy, John

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 3 | Issue: 1 | Pages: 109-116

10.3233/jad-2001-3115 | PMID 12214079 Get It

CAHPS Cancer Care Survey: Development, testing, and final content of a survey of patient experience with cancer care.
Evensen, Christian, Yost, Kathleen J. , Keller, San, Cowans, Tamika, Frentzel, Elizabeth , Jenkins, Sarah M. , Egginton, Jason S. , Arora, Neeraj, Garfinkel, Steven

Journal of Clinical Oncology | April 5, 2017 | Volume: 35 | Issue: 8_suppl | Pages: 227-227

10.1200/jco.2017.35.8_suppl.227 Get It

227 Background: The objective of this work was to develop a reliable and valid survey measuring aspects of cancer care important to patients to be used in both inpatient and outpatient settings, and that allows comparisons of patient experiences across treatment centers and treatment modalities (medical oncology, radiation, surgery). Other objectives included testing various modes of data collection and developing a standardized sampling methodology based on ICD diagnosis and procedure codes. Methods: We conducted focus groups with patients who had received cancer treatment and with family members of cancer patients. We convened a panel of experts representing quality improvement, oncology, shared decision-making, patient safety, and patient advocacy to obtain feedback on the development of the survey. We interviewed stakeholder groups representing oncology associations to obtain feedback on focal provider, attribution and sampling. We then conducted a field test of the survey among six cancer centers around the country, conducted psychometric analyses, revised the survey, conducted a second field test among four community oncology practices in CA, re-analyzed the data, and finalized the survey. Results: Final survey content was determined using results of the formative research, psychometric analyses, and input from the CAHPS Consortium. The core survey includes 56 questions, 23 of which map to eight composites: Provider Communication, Enabling Patient Self-management, Team Available to Provide Information, Access to Care, Care Coordination, and Office Staff. Supplemental item sets include seven items assessing Shared Decision Making, four items measuring Keeping Patients Informed, and two additional Access to Care items. Mail-only, mail-telephone mixed-mode, and web-mail mixed-mode are recommended methods of data collection. The survey and all recruiting materials are available in English and Spanish. Conclusions: The CAHPS Cancer Care Survey is a rigorously developed, well-tested, reliable and valid survey of patient experiences with their cancer care. The survey and supporting materials are available free of charge on the CAHPS website (www.ahrq.gov/cahps).